Curaleaf (CURA.TO), an international provider of consumer cannabis products, announced Tuesday that a 1-for-3 reverse stock split of its shares will become effective on or about June 5, 2026, as the company prepares for U.S. Stock Exchange uplisting, in response to cannabis rescheduling in that country.
Curaleaf's board has approved a proposal to effect a reverse stock split of the company's subordinate voting shares at a ratio of one post-consolidation share for each three pre-consolidation shares, a statement said. This initiative is being done in consultation with major U.S. stock exchanges, and is expected to enable the company to uplist as soon as the opportunity is available, it added.
Shares in CURA rose $0.08 or 1.7% at $4.70 in Canada yesterday.